Abstract: Due to the presence of numerous bioactive compounds, including polysaccharides and polyphenols, mushroom-based food supplements have been claimed to have many beneficial health effects. Despite the popularity, concerns have been raised over the quality of mushroom products in recent years, particularly regarding their non-standardized chemical composition. In this study, we analyzed β-glucan and total phenolic contents, as well as the antioxidant potential of mushroom-derived supplements available in the Serbian market. The obtained results, revealing considerable differences in β-glucan and total polyphenol contents among these products, reflect variations in mushroom species, forms and recommended dosing regimens. A correlation between the total phenolic content and antioxidant activity was observed. The presence of other active ingredients, such as vitamin C, has contributed to antioxidant variability among analyzed products. The obtained results indicate the need for the standardization of mushroom-derived food supplements to ensure their claiming effects.
INTRODUCTION
Mushrooms are widely consumed in many parts of the world due to their nutrient contents, as well as consequently recognized health benefits. Their important nutritional value is based on low calories, fat and sodium while being quite rich in protein, dietary fibre, vitamins and minerals. 1 Beside that, mushrooms are rich in bioactive secondary metabolites, including polysaccharides, phenolic compounds, glycopeptides, polyketides, terpenoids and saponins. 2 Among these compounds, the most distinguishable are polysaccharides which have been extensively studied, 3 especially β-glucans with the range of dry matter content of 15-22 %. 4 Unlike the β-glucans present in cereals, which have β-(1→3) (1→4) linkages, the β-glucans in the fungal cell wall, mainly contain β-(1→3) (1→6) linkages. 5 Opposite to β-glucans from yeast, mushroom-derived β-glucans usually have shorter side chains. 6 Beside degree branching, other factor like molecular weight, conformation and solubility are the factors that significantly impact its biological activity. 7 Due to the β-glucans content, mushrooms have been shown to have prominent immunomodulatory activities. 8 Since these compounds cannot be synthesized endogenously, they are recognized by the immune system initiating both adaptive and innate immune responses. 9 Some of mushrooms β-glucans have shown potent anticancer properties. 10 Also, there is an increasing body of evidence that mushroom β-glucans pose antidiabetic, hypocholesterolemic, antiobesity, antihypertensive, wound healing, hepatoprotective and other beneficial effects. 11, 12 Besides polysaccharides, mushrooms contain a wide range of bioactive compounds, including phenolics, tocopherols, carotenoids, glycosides, ergothioneine and ascorbic acid 13 , which all together contribute to a higher antioxidant potential of mushrooms than most vegetables and fruits have. 14 Therefore, growing evidence of health-promoting effects of mushroom and their compounds, led to increased number of products in the fungi-based supplements market. 15 These products contain refined, or partially refined extracts, dried fruiting bodies or mycelium, from reishi (Ganoderma lucidum), shiitake
(Lentinus edodes), maitake (Grifola frondosa), cordyceps (Cordyceps sinensis)
and Chaga (Inonotus obliquus) in the form of capsules, tablets, powder or liquids. 16 In parallel with popularity, due to the lack of standardization requirements, there is a rising concern regarding the effectiveness of these products. This in particular can be contributed to economically motivated adulteration and intentional substitution of mushroom-derived materials by some less expensive or lower quality ones. 16, 17 Therefore, requirement for chemical insights into the quality of mushroom supplements, based on the content of bioactive compounds, such as polysaccharides, has been recognized. 18 However, the quality of such products has not been a subject of extensive studies. Apart from acting as natural immuneity enhancers, these products are also often claimed to be antioxidant capacity boosters, 19 without giving information related to the antioxidant capacity effectiveness. Therefore, the purpose of this study was to evaluate the β-glucan content, as well as polyphenol content and antioxidant capacity of mushroom-derived supplements present on the Serbian market. Moreover, obtained results in the recommended daily dose (dd) for each analysed supplement were compared with serving size of shiitake mushrooms, selected on the evidence for the effectiveness of its regular consumption. 20 
EXPERIMENTAL

Standards and reagents
Trolox (97 %), TPTZ (2,4,6-tris(2-pyridyl)-s-triazine), DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS (2,20-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) were obtained O n L i n e F i r s t from Sigma-Aldrich (St. Luis, MO, USA). Gallic acid (98 % purity) was purchased from Acros Organics (New Jersey, USA). Folin-Ciocalteu reagent (FC), sodium carbonate, ferric chloride hexahydrate, potassium peroxodisulfate, neocuproine and copper (II) chloride were supplied from Merck (Darmstadt, Germany). All the reagents were of analytical grade.
Samples and sample preparations
Samples (n=16) were food supplements commercially available in Serbian pharmacies and health food stores. Their selection was based on the content of mushroom-derived preparations (powder, extract or isolated compounds), either as a single active component or in various combinations. Detailed characteristics of analysed supplements, labelled by the producer, are presented in Table I . 
O n L i n e F i r s t
Samples, or the inner part of the capsules, were weighted (1 g of each) and 10 ml of distilled water was added. The mixtures were vortexed and after 1 hour of extraction in the ultrasonic bath (FALC Instruments, Italy), samples were centrifuged at 3000 rcf for 15 minutes (Janetzki T32C, Wallhausen, Germany). The supernatants were filled up to obtain 50 ml in a flask. Obtained extracts were immediately used for total phenolic content and antioxidant activities analysis.
Fresh fruiting bodies of shiitake mushrooms (Lentinula edodes) were purchased at a local market. Mushrooms (50 g) were cleaned, mashed and then macerated with 100 ml of distilled water at room temperature for 24 hours. The mixture was centrifuged at 3000 rcf for 15 minutes, and the supernatant was removed and filtered through Whatman No. 1 filter paper. For phenolic content and antioxidant activities evaluation, supernatant was filled up to obtain 200 ml in a flask.
Original mushroom supplement weighted samples (or the inner part of the capsules) and shiitake mushroom dried at room temperature were used for determination of β-glucan content.
Determination of total phenolic content (TPC)
Total phenolic content was determined using rapid Folin-Ciocalteu microassay. 21 Reaction mixtures (extracts (10 μL), ten times diluted Folin-Ciocalteu's reagent (100 μL) and 1M Na2CO3 (80 μL) were incubated in 96-well microplate for 1 h in the dark. The absorbance of the solutions was read at 630 nm on an MTP reader (BIOTEK, USA, ELx800 118 Absorbance Microplate Reader). Gallic acid was used to obtain the standard curve and results were expressed as milligrams of gallic acid equivalents (mg GAE) per g of the weighted samples and recommended daily doses for the mushroom-derived supplements and as mg of GAE per serving size (72.5 g) for the shiitake mushrooms.
22
Determination of antioxidant activity ABTS/TEAC (Trolox equivalent antioxidant capacity) radical scavenging microassay ABTS test was done using the method proposed by Pastoriza et al. 23 Stock solutions of ABTS (14 mM) and potassium peroxodisulfate (4.9 mM) in phosphate buffer (pH 7.4) were prepared and mixed in equal volumes. The mixture was left over night at room temperature and was then diluted with phosphate buffer to achieve an absorbance of 0.7±0.02 at 734 nm. In order to determine the scavenging activity, 20 μl of aliquoted extracts were mixed with 280 μl of the ABTS solution in 96-well microplate. The absorbance was measured after 6 min at 630 nm using MTP reader. Calibration curve of Trolox was used for quantification of antioxidant activity. Results were expressed as μM Trolox Equivalents (TE) per recommended daily doses for the mushroom-derived supplements and as μM TE per serving size for the shiitake mushrooms.
Diphenylpicrylhydrazyl (DPPH) radical scavenging microassay DPPH microassay was performed as it was described previously. 24 Briefly, 7 μl of diluted extracts were mixed with 193 μl of the DPPH radical solution (60 μM) in microplate wells. Absorbance readings were taken after 1h of reaction at 490 nm on MTP reader. Trolox was used in order to construct the standard curve, so results were expressed as μM Trolox Equivalents (TE) per recommended daily doses for the mushroom-derived supplements and as μM TE per serving size for the shiitake mushrooms.
O n L i n e F i r s t
Ferric ion reducing antioxidant power (FRAP) microassay Antioxidant activity was determined using FRAP microassay according to Bolanos et al. with some modifications. 25 FRAP reagent was prepared by mixing acetate buffer (pH 3.6), TPTZ solution (2,4,6-tripyridyl-s-triazine in 40 mM HCl) and 20 mM FeCl3×6H2O in 10:1:1 volume ratio. Aliquoted extracts (20 μl) were allowed to react with 280 μl of FRAP reagent in 96-well microplate. After 30 min at 37 °C the absorbance readings were taken at 630 nm on MTP reader. Standard curve was made by Trolox and results were expressed as μmol Trolox Equivalents (TE) per recommended daily doses for the mushroom-derived supplements and as μM TE per serving size for the shiitake mushrooms.
Cupric Ion Reducing Antioxidant Capacity (CUPRAC) microassay
This method was done according to Zengin et al. with modifications. 26 After placing a 67 μl of diluted extracts in 96-well microplate, 61 μl of 0.01 M CuCl2, 61 μl of 7.5 μM neocuproine and 61 μl of ammonium acetate buffer (pH 7.0) were added, respectively. After 30 min of incubation, absorbance reading was made against a reagent blank at 450 nm. Trolox was used to obtain the standard curve and results were expressed as μM Trolox Equivalents (TE) per recommended daily doses for the mushroom-derived supplements and as μM TE per serving size for the shiitake mushrooms.
ACI (Antioxidant potency composite index)
Results obtained from in vitro antioxidant assays (ABTS, DPPH, FRAP and CUPRAC) allowed calculating antioxidant composite index (ACI). 27 An index value of 100 is assigned to the best score for each assay.
An index score for all samples was calculated as follows:
Sample score Antioxidant index score 100 Best score = (1) ACI values were created by averaging all four assays for each sample.
Determination of β-glucan content
β-glucan content was quantified by a spectrophotometric method using the enzymatic assay kit K-YBGL (Megazyme, Bray, Wicklow County, Ireland) according to the manufacturer's instructions. This assay combines hydrolysis steps with enzymatic incubation and determines total glucan as well as α-glucan content. β-glucan was calculated by subtracting the α-glucan content from the total glucan content. Total glucan fragments are quantitatively hydrolysed to glucose using a mixture of exo-1,3-beta-glucanase and alpha-glucosidase. Afterward, α-glucans are specifically determined, by hydrolysis of the glucans to glucose, using amyloglucosidase plus alpha-amylase and later by glucose-oxidase-peroxidase-determination (GOPOD) reagent. All measurements were performed at 510 nm. Results were expressed as grams of β-glucan per 100 g of the weighted samples and as milligrams of β-glucan per recommended daily doses for the mushroom-derived supplements, as well as per serving size for the shiitake mushrooms.
Statistical analysis
All analyses were performed in triplicate and obtained results were presented as the mean values and the standard deviations (SD). Spearman's correlation coefficient was used to calculate the correlations between data. Statistical analyses were completed using the computer program SPSS (version 20, Chicago, Ill., U.S.A.) and a p value <0.05 was considered statistically significant.
O n L i n e F i r s t
Principal component analysis (PCA) was performed to identify and visualize relationships between the antioxidant composite index (ACI) of mushroom-derived supplements and their respective total phenolic content (TPC), β-glucan and labeled content of vitamin C, per daily doses. PCA was performed with the software Past 3.25.
RESULTS AND DISCUSSION
The results of β-glucan content in the mushroom-derived food supplements are summarized in Table II . They varied from 4.54 g (100 g) -1 (P3) to 37.49 g (100 g) -1 (C8). These values are in accordance with the previous study 29 , which revealed considerable differences in β-glucan content among commercial mushroom products. Namely, not only mushroom species and the type of mushroom materials, but also ways of cultivation and extraction procedures probably contribute to the observed variability. 30 Ganoderma lucidum (reishi) is known to have more than 200 different polysaccharides which are isolated from fruiting bodies, mycelium, spores or liquid cultures. 31 In recent years, there has been an increasing concern about the quality of reishi products. 32 In an analysis of polysaccharide and triterpene profiles, Wu et al. found that only 26.3 % of the Ganoderma lucidum supplements were in accordance with their labels. 18 This study also found the significant variations in the β-glucan content among reishi supplements. The lowest β-glucan content was observed for sample P2 in the form of reishi spores powder. Within samples based on reishi fruiting bodies extracts, β-glucan content ranged between 8.44 g (100 g) -1 (C6) and 33.25 g (100 g) -1 (C8), reflecting differences in the qualitative and quantitative composition among them.
Mushroom-based product dose in traditional medicine should correspond to 100-150 g of raw materials. However, the consensus for the effective dosage for mushroom supplements has not been established. According to clinical trials, the accepted daily dose is 3000-6000 mg of biomass or mushroom extracts. 16 When obtained results were expressed per maximum daily doses established by manufactures, the content of β-glucan was up to 1000 mg with an average concentration of 293 mg (Table II) . The Chaga powder supplements (P3) provide the highest amount of β-glucan (953.40 mg dd -1 ), followed by mixed mushroom supplements S3 (764.82 mg dd -1 ) and C10 (653.74 mg dd -1 ), respectively. These results indicate that mushroom supplements provide less β-glucans intake than one serving size of shitake (2078.21 mg).
Interestingly, α-glucan contents in this study were low and ranged from 0.13 g (100 g) -1 to 2.32 g (100 g) -1 (data not shown in Table II ). In contrast to earlier findings, 18, 28 these results indicate the absence of starch-based excipients, like starch or maltodextrins, as possible adulterants in analysed mushroom supplements. Mushrooms are recognized as good source of dietary polyphenols. 33 Depending on the mushroom species, the total polyphenols content range from 1 to 6 mg g -1 of dried weight. 34 In addition to antioxidative properties, numerous studies have revealed that mushroom phenolic compounds exert anti-inflammatory, antimicrobial, anticancer, antiviral, neuroprotective and other healthpromoting effects. 35 Total phenolic contents ranged from 0.45 mg GAE g -1 (S3) to127.43 GAE g -1 (C4) ( Table II) . Since many other, non-phenolic reducing compounds, may interfere in the Folin-Ciocalteu assay, by far the highest value of TPC in the extract of sample C4, in comparison with other extracts, could be explained by high labelled content of vitamin C. As expected, higher levels of TPC were noticed among mushroom extracts mixed with herbal materials (C1, C3, and C7).
O n L i n e F i r s t
Similar to the β-glucan content, difference in the polyphenol content among mushroom supplements could be due to different mushroom species, type of the mushroom product, as well as various processing factors, which makes comparison difficult. Stilinovic et al. 36 studied total phenolics of commercial preparations of edible mushrooms and showed that methanol extract from the powder of Cordyceps sinensis contained three times more total phenolics than from Ganoderma lucidum. In this study, we obtained the opposite results for supplements from the same producers (C1 and C2), which contained the same quantity of extracts of these mushroom species. When recommended daily doses O n L i n e F i r s t were taken into account, the average TPC in analysed mushroom supplements was 21 mg GAE dd -1 . The content of polyphenols in the sample C4 (159 mg GAE dd -1 ) corresponds only to half of the intake that can be obtained from a single serving of shiitake mushrooms.
Due to prevalent consumption, it was estimated that food supplements contribute to the 25 % of total antioxidant daily intake. 37 However, due to different origin, preparation processes, formulations and concentrations of their active ingredients, great variability in antioxidant capacity was revealed among the supplements. 38 In order to extensively evaluate the antioxidant potential of the mushroom-derived supplements, different assays based on the transfer of electrons (DPPH, ABTS) and reducing power ability ferrous (FRAP) and cupric ions (CUPRAC) were employed. Taken into account differences in total unit mass and dosage regimen among different forms of supplements, antioxidant activity was expressed per maximum daily dose recommended by the producers (Table III) . Namely, based on obtained results, antioxidant activity was mathematically recalculated by one unit of products (gram or milliliter) and then multiplied by the maximum daily amount labelled on the product package. Although in vitro antioxidant capacity cannot be directly translated to biological systems, ACI presents a useful tool for ranking different commercial products. 27 As it could be seen, the sample C4 had the highest ACI, followed by sample P3 and C7. A significant correlation was found between the TPC and the ACI values (p<0.001). However, no significant correlation between β-glucan content and ACI, nor with any of the antioxidant activities was observed. Since that majority of analysed products are based on mushroom extracts, these results could be explained by the fact that purified polysaccharides, free of phenolic compounds and proteins have low antioxidant activity. 40 Except for the sample C4, one serving of shiitake provides better antioxidant potency than mushroombased supplements.
According to the PCA results, two principal components were sufficient to capture the variability of the sample properties. The first component, represented as the X-axis, describes the 71.06 % of the variability, whereas the second component, represented as the Y-axis, describes the 26.77 % of the variability. For further analysis of the variability sources, scores and loadings were plotted and the bi-plot is represented in Fig 2. The first component describes the majority of the variation between the samples and it is represented by a combination of the ACI, total phenolic content and vitamin C per daily dose, since these three variables have the positive first component (i.e. X-axis) coordinates and, according to the loadings' values, contribute to the first component. This is indicative of the positive correlation between these three variables, and it is demonstrative of the fact that the product C4 with the highest ACI also had the highest TPC and labelled vitamin C content per daily dose. Table IV . capacities. Using PCA, the variability of daily doses in β-glucan content was less than in their antioxidant capacity. Addition of other active ingredients, like vitamin C, impact on antioxidant variability. In addition to the need for standardization for commercial mushroom-based products, obtained results did not support the fact that usage of these products could contribute more β-glucan and dietary antioxidant intake than regular consumption of shiitake mushrooms as part of an optimal balanced diet.
O n L i n e F i r s t
